The future of Novartis

April 9, 2019

Our future is as a leading focused medicines company, powered by data science and advanced therapy platforms. CEO Vas Narasimhan shares our vision

Spotlight

Aspen Pharma Brasil

Aspen Pharma Brazil is a subsidiary of Aspen Pharmacare, the leading brand in Africa and one of the 20 largest branded generic brand in the world. Aspen Pharmacare has 18 production plants in 14 countries on six continents, and supplies medicines to more than 150 countries. The Group officially entered the Brazilian drug market in 2009 after acquiring 100% of Cellofarm, headquartered in Rio de Janeiro. Aspen do Brasil's mission is to supply the domestic market, in addition to ensuring the Group's expansion in Latin America, focusing on growth through global acquisitions with other multinationals.

OTHER VIDEOS

Welcome to the Azelis Pharma lab in Paris, France!

video | January 30, 2023

As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities....

Watch Now

Daikyo Crystal Zenith® Insert Needle Syringe

video | January 27, 2023

The Daikyo Crystal Zenith® Insert Needle Syringe system was designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies....

Watch Now

Little Green Pharma continues to expand making significant strides

video | January 31, 2023

Leading Australian medicinal cannabis exporter, Little Green Pharma continues to expand making significant strides in lucrative global markets...

Watch Now

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

video | January 26, 2023

Teva believes medicine should always be accessible, and we work to help make this a reality. We're working with Global HOPE (Hematology Oncology Pediatric Excellence), a non-profit...

Watch Now

Spotlight

Aspen Pharma Brasil

Aspen Pharma Brazil is a subsidiary of Aspen Pharmacare, the leading brand in Africa and one of the 20 largest branded generic brand in the world. Aspen Pharmacare has 18 production plants in 14 countries on six continents, and supplies medicines to more than 150 countries. The Group officially entered the Brazilian drug market in 2009 after acquiring 100% of Cellofarm, headquartered in Rio de Janeiro. Aspen do Brasil's mission is to supply the domestic market, in addition to ensuring the Group's expansion in Latin America, focusing on growth through global acquisitions with other multinationals.

Events